Eisai
4523.T
#1977
Rank
โ‚น701.06 B
Marketcap
โ‚น2,487
Share price
-0.93%
Change (1 day)
-27.78%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): โ‚น179.60

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น190.61. In 2022 the company made an earnings per share (EPS) of โ‚น139.93 a decrease over its 2021 EPS that were of โ‚น621.23.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น179.6028.35%
2022โ‚น139.93-77.48%
2021โ‚น621.23-41.88%
2020โ‚น1,069-0.94%
2019โ‚น1,07952.59%
2018โ‚น707.10124.17%
2017โ‚น315.43-49.42%
2016โ‚น623.6937.08%
2015โ‚น454.99-11.75%
2014โ‚น515.54-3.23%
2013โ‚น532.76-18.56%
2012โ‚น654.20-15.51%
2011โ‚น774.32-3.75%
2010โ‚น804.53-1.36%
2009โ‚น815.61